Market News

Moderna shares fall after company cuts 2021 forecast for Covid vaccine sales


Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021.

Boston Globe | Getty Images

Moderna shares fell 8% on Thursday after it cut its Covid-19 vaccine sales forecast for the year to between $15 billion and $18 billion from $20 billion.

This is a developing story. Please check back for updates.

Tough times for income investors: Even with payouts at a record, dividend yields are measly

Previous article

Ford to repurchase up to $5 billion in junk bonds as it restructures its balance sheet

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Market News